CoChat

Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery

Open access
M. Scott, Latanya, R. Lawrence, Harshani, M. Sebti, Said, J. Lawrence, Nicholas, Wu, Jie · 2010 · Current Pharmaceutical Design
Cited by 156

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Protein tyrosine phosphatases (PTPs) are a diverse family of enzymes encoded by 107 genes in the human genome. Together with protein tyrosine kinases (PTKs), PTPs regulate various cellular activities essential for the initiation and maintenance of malignant phenotypes. While PTK inhibitors are now used routinely for cancer treatment, the PTP inhibitor development field is still in the discovery phase. In this article, the suitability of targeting PTPs for novel anticancer drug discovery is discussed. Examples are presented for PTPs that have been targeted for anticancer drug discovery as well as potential new PTP targets for novel anticancer drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/138161210791209027

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 156

Metadata

Authors
M. Scott, L., R. Lawrence, H., M. Sebti, S., J. Lawrence, N., & Wu, J.
Venue
Current Pharmaceutical Design
Published
2010-06-01
Volume
16
Issue
16
Pages
1843-1862
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2142682969
Cited by
156
References
10
FWCI
3.90
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery. https://app.cochat.ai/papers/10.2174/138161210791209027
The paper
M. Scott, L., R. Lawrence, H., M. Sebti, S., J. Lawrence, N., & Wu, J. (2010). Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery. Current Pharmaceutical Design. https://doi.org/10.2174/138161210791209027

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.